{
  "ranked_diseases": [
    {
      "disease_name": "3-Methylglutaconic Aciduria, Type III (Costeff Syndrome)",
      "disease_id": "OMIM:258501",
      "score": 1.0,
      "explanation": "This condition is characterized by spastic diplegia, intellectual disability, seizures, and cerebral atrophy, which are prominent features in the patient's phenotype."
    },
    {
      "disease_name": "SPG11 (Hereditary Spastic Paraplegia Type 11)",
      "disease_id": "OMIM:604360",
      "score": 0.5,
      "explanation": "SPG11 often presents with thin corpus callosum, spastic diplegia, intellectual disability, and cerebral atrophy, matching several of the patient's symptoms."
    },
    {
      "disease_name": "Cohen Syndrome",
      "disease_id": "OMIM:216550",
      "score": 0.333,
      "explanation": "Cohen Syndrome includes intellectual disability, delayed speech, obesity, and prominent nasal bridge, which are seen in the patient."
    },
    {
      "disease_name": "MEGDEL Syndrome",
      "disease_id": "OMIM:614739",
      "score": 0.25,
      "explanation": "This syndrome involves seizures, global developmental delay, cerebral atrophy, and thin corpus callosum, aligning with the patient's features."
    },
    {
      "disease_name": "Pitt-Hopkins Syndrome",
      "disease_id": "OMIM:610954",
      "score": 0.2,
      "explanation": "Pitt-Hopkins Syndrome is marked by delayed development, seizures, and thin corpus callosum, which are present in the patient."
    }
  ]
}